Small/medium drug companies experiencing duplicate difficulties.

Small and medium sized pharmaceutical companies have faced with duplicated difficulties with the competition against the upper leading rivals and the discriminated assessment system by the GMP.

The small and medium sized pharmaceutical industry said that they should compete local and foreign multinational drug corporations with inferior product lines and poor marketing promotional investmen...